MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11010-021-04273-4

Медицинская библиотека · Molecular and cellular biochemistry · 2021

Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications.

Mao Chenyu, Ding Yongfeng, Xu Nong

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Prostate cancer (PCa) is one of the most common cancers in men and the cause of numerous cancer deaths in the world. Nowadays, based on diagnostic criteria, prostate-specific antigen (PSA) evaluation and rectal examination are used to diagnose prostate-related malignancies. However, due to the different types of PCa, there are several doubts about the diagnostic value of PSA. On the other hand, semen is considered an appropriate source and contains various biomarkers in non-invasive diagnosing several autoimmune disorders and malignancies. Evidence suggests that analysis of semen biomarkers could be helpful in PCa diagnosis. Therefore, due to the invasiveness of most diagnostic methods in PCa, the use of semen as a biologic sample containing various biomarkers can lead to the emergence of novel and non-invasive diagnostic approaches. This review summarized recent studies on the use of various seminal biomarkers for diagnosis, prognosis and prediction of PCa.

Для цитирования: Mao Chenyu, Ding Yongfeng, Xu Nong. Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications.. Molecular and cellular biochemistry. 2021. DOI: 10.1007/s11010-021-04273-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.